Mesenchymal stem cells in the treatment of COVID-19, a promising future

DG Beghini, SI Horita, A Henriques-Pons - Cells, 2021 - mdpi.com
stem cells (MSCs) are multipotent adult stem cells present in virtually all tissues; they have
a potent self-renewal capacity and can differentiate into multiple cell … of other stem cells’ …

Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effects

K Nasiri, S Mohammadzadehsaliani… - Cell Communication and …, 2023 - Springer
… Pluripotent hematopoietic progenitors keep blood cells in circulation. These hematopoietic
stem cells (HSCs) are uncommon pluripotent cells in the BM that express CD34 surface …

Stem cell therapy potency in personalizing severe COVID-19 treatment

A Basiri, F Mansouri, A Azari, P Ranjbarvan… - Stem Cell Reviews and …, 2021 - Springer
… its possible aspects in COVID-19 treatment; and then review the cell-based therapy studies
for … will describe stem cell-based therapy as a precision therapeutic candidate for COVID-19

[HTML][HTML] Research progress on mesenchymal stem cells (MSCs), adipose-derived mesenchymal stem cells (AD-MSCs), drugs, and vaccines in inhibiting COVID-19 …

P Gentile, A Sterodimas, J Pizzicannella… - Aging and …, 2020 - ncbi.nlm.nih.gov
… This article reviewed, at the current day, the research progress on stem cell therapy in
COVID-19 patients, and in particular focused on the clinical research status of MSCs and AD-…

Stem cell-based therapy for COVID-19 and ARDS: a systematic review

G Zanirati, L Provenzi, LL Libermann… - NPJ Regenerative …, 2021 - nature.com
… The present systematic review evaluated the available results of stem cell therapy for treating
patients with COVID-19 and ARDS. By July 2021, according to the US National Institutes of …

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

A Sharma, NS Bhatt, A St Martin, MB Abid… - The Lancet …, 2021 - thelancet.com
stem-cell transplantation (HSCT) recipients are considered at high risk of poor outcomes after
COVID-19 … of hematopoietic stem cell transplantation recipients with COVID-19 diagnosis …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human cell, 2020 - Springer
COVID-19, when scientists around the world are working on a number of vaccines and
treatments for COVID-19, mesenchymal stem cells … and healing potential of stem cells and their …

Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia

Y Zhang, J Ding, S Ren, W Wang, Y Yang, S Li… - Stem cell research & …, 2020 - Springer
… Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful
… results in COVID-19 treatment. Here, we report a case of a severe COVID-19 patient treated …

[PDF][PDF] Using cardiovascular cells from human pluripotent stem cells for COVID-19 research: why the heart fails

L Yiangou, RP Davis, CL Mummery - Stem Cell Reports, 2021 - cell.com
… how hPSC-derived cardiovascular cells have been utilized to study COVID-19, and their …
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 …

SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells

JH Jung, MS Rha, M Sa, HK Choi, JH Jeon… - Nature …, 2021 - nature.com
cells (Fig. 4e), confirming that SARS-CoV-2-specific T SCM cells are bona fide stem-like
memory cells… the detailed stem cell-like properties of SARS-CoV-2-specific T SCM cells. We …